Another Record Falls in Q1:15

by | Apr 4, 2015 3:19 pm | Behavioral Health Care, Biotechnology, Home Health & Hospice, Hospitals, Laboratories, MRI & Dialysis, Long-Term Care, Managed Care, Medical Devices, Other Services, Pharmaceuticals, Physician Medical Groups, Rehabilitation

Now that the month is officially over, we can report our preliminary Q1:15 results—and it was another record breaker, at least for transactions. The 346 deals logged so far are 109% higher than the first quarter of 2014. You would think that the $104.7 billion in combined spending would set another record, but no. In Q1:09, we tracked $127.2 billion spent on 202 deals. That’s when Pfizer (NYSE: PFE) bought Wyeth for $68 billion.  Here’s the preliminary breakdown of Q1:15 — and remember, the spending is only for deals that disclosed prices. Read More »

Ambry Genetics Completes Itself with Progeny

by | Apr 4, 2015 3:08 pm | Laboratories, MRI & Dialysis

Privately held Ambry Genetics, a clinical genetic diagnostics laboratory, wasn’t joking around when it acquired Progeny Software, LLC on April 1. Progeny Software has spent the last 15 years enhancing its software to manage all types of genetic data, from pedigrees, providing genotype management and analysis, or providing a full laboratory information management system (LIMS). The combination, for an undisclosed price, gives Ambry the ammo to call itself a complete genetics services company “on the forefront of personalized medicine.” Don’t say we didn’t warn you. Read More »